Evidence map›Paper›PMID 24673557›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2014

Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells.

Kristina K Aenlle, Kevin M Curtis, Bernard A Roos, Guy A Howard

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. CRISPR/Cas9-Mediated Overexpression ofInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kristina K AenlleGeriatric Research, Education, and Clinical Center and Research Service (K.K.A., K.M.C., B.A.R., G.A.H.), Veterans Affairs Medical Center, Miami, Florida 33125; Departments of Medicine (B.A.R., G.A.H.), Neurology (B.A.R.), and Biochemistry & Molecular Biology (K.M.C., G.A.H.), University of Miami Miller School of Medicine, Miami, Florida 33101.
Kevin M Curtis
Bernard A Roos
Guy A Howard
Geriatric Research Education and Clinical Center · USUniversity of Miami · US

Funding

Osteogenic Maturation and Bone Repair Require 1,25- and 24,25-dihydroxyvitamin DF32AR062990 · NIAMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CURTIS, KEVIN MATTHEW · 2012 to 2015
$172k
NIAMS NIH HHS 7F32AR062990NIAMS NIH HHS F32 AR062990
6 · The paper itself

Abstract

Hepatocyte growth factor (HGF) is a paracrine factor involved in organogenesis, tissue repair, and wound healing. We report here that HGF promotes osteogenic differentiation through the transcription of key osteogenic markers, including osteocalcin, osterix, and osteoprotegerin in human mesenchymal stem cells and is a necessary component for the establishment of osteoblast mineralization. Blocking endogenous HGF using PHA665752, a c-Met inhibitor (the HGF receptor), or an HGF-neutralizing antibody attenuates mineralization, and PHA665752 markedly reduced alkaline phosphatase activity. Moreover, we report that HGF promotion of osteogenic differentiation involves the rapid phosphorylation of p38 and differential regulation of its isoforms, p38α and p38β. Western blot analysis revealed a significantly increased level of p38α and p38β protein, and reverse transcription quantitative PCR revealed that HGF increased the transcriptional level of both p38α and p38β. Using small interfering RNA to reduce the transcription of p38α and p38β, we saw differential roles for p38α and p38β on the HGF-induced expression of key osteogenic markers. In summary, our data demonstrate the importance of p38 signaling in HGF regulation of osteogenic differentiation.

Indexed as

Cell DifferentiationAntigens, DifferentiationCells, CulturedChildChild, PreschoolHepatocyte Growth FactorHumansMaleMAP Kinase Signaling SystemMesenchymal Stem CellsMitogen-Activated Protein Kinase 11Mitogen-Activated Protein Kinase 14OsteogenesisPhosphorylationProtein Processing, Post-TranslationalProto-Oncogene Proteins c-metAntigens, DifferentiationHepatocyte Growth FactorHGF protein, humanMitogen-Activated Protein Kinase 11Mitogen-Activated Protein Kinase 14Proto-Oncogene Proteins c-met

Identifiers

PMID24673557
PMCPMC4004777
OpenAlexW1992016301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.